30-Day and 1-Year Acute Myocardial Infarction Outcomes in Côte d'Ivoire: The REACTIV Study

科特迪瓦急性心肌梗死患者30天和1年预后:REACTIV研究

阅读:1

Abstract

BACKGROUND: Whereas the increasing burden of acute myocardial infarction (MI) has been reported in sub-Saharan Africa, little is known about short- and long-term prognosis following acute MI. OBJECTIVES: The purpose of this study was to assess in-hospital, 30-day, and 1-year all-cause mortality and adverse outcomes in patients with MI hospitalized at a cardiac center in Côte d'Ivoire. METHODS: This prospective cohort study used data from the REgistre des syndromes coronariens Aigus de CôTe d'IVoire (REACTIV). All consecutive patients admitted to the intensive care unit with acute MI were included. The primary endpoints included in-hospital, 30-day, and 1-year all-cause mortality and major adverse cardiovascular events. Multivariable Cox regression analyses were performed to identify factors associated with 30-day and 1-year all-cause mortality. RESULTS: A total of 272 participants were included (average age 56.93 ± 11.1 years, 76.8% men). The in-hospital mortality was 9.9%. Mortality rates and major adverse cardiovascular events were 11% and 2.8% at 30 days and 21.7% and 27.3% at 1 year, respectively. In the multivariable regression model, factors associated with 30-day all-cause mortality were Killip stage ≥2 at admission (relative risk [RR]: 3.65; 95% CI: 1.61-8.26) and impaired renal function (RR: 3.44; 95% CI: 1.63-7.26). One-year all-cause mortality was associated with Killip stage ≥2 at admission (RR: 2.74; 95% CI: 1.52-4.94), anterior MI (RR: 2.48; 95% CI: 1.37-4.48), impaired renal function (RR: 3.44; 95% CI: 1.63-7.26), and sustained ventricular tachycardia (RR: 5.24; 95% CI: 2.67-10.3). At both 30-day and 1-year follow-up, myocardial reperfusion therapies improved prognosis. CONCLUSIONS: Acute MI is associated with substantial mortality and morbidity in Côte d'Ivoire. These data can help local care providers identify those at highest risk and plan surveillance accordingly.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。